April, 2024
April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Erman Akkus: Is adjuvant Gem-Cis better than capecitabine in operated node-positive extrahepatic cholangiocarcinoma?
Apr 2, 2024, 05:45

Erman Akkus: Is adjuvant Gem-Cis better than capecitabine in operated node-positive extrahepatic cholangiocarcinoma?

Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter:

“Is adjuvant Gem-Cis better than capecitabine in operated node-positive extrahepatic cholangiocarcinoma? STAMP trial: Not a negative study.

  • 101 patients
  • 31.7% had R1 resection
  • 2-year disease-free survival: 38.5% vs 25.1% (HR=0.96 (CI, 0.71–1.30), p=0.430)
  • median overall survival: 35.7 mo (29.5–NE) vs 35.7 months (30.9–NE) [HR=1.08 (CI, 0.71–1.64), 1-sided p=0.404)
  • Grade 3–4 AE: 84% vs 16%”

Read further.
Source: Erman Akkus/X